Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d5ce3abc4c50ceecbe831e15be26224 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96e1bced372ca18c832f733eac7bed7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f4d86235703b3e2a1cb10b98722d80d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-575 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2012-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc94d72858231f64730e9d14e2500ee9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a24cf19a93e4c4b971ce8f6f370af30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c44d0f7acf341cbaa127c91bf17b5f94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3781fd0522bb83a64da7e0cae0b5baa0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25d113ed7871cdb1359489cfd909e953 |
publicationDate |
2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2773960-A1 |
titleOfInvention |
Diagnostic and treatment of an androgen-independent prostate cancer |
abstract |
The present invention relates to a method for monitoring the tumor growth of an androgen-independent prostate cancer in a subject, by determining the amount of at least one adrenomedullin receptor and optionally adrenomedullin in a prostate cancer cell obtained from said subject. The present invention also relates to a pharmaceutical composition comprising an anti-adrenomedullin antagonist antibody and/or at least one anti-adrenomedullin receptor antagonist antibody for treating an androgen-independent prostate cancer. |
priorityDate |
2011-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |